SCHEMBL6634815

SCHEMBL6634815

Cn1c(CNc2ccc(C#N)cc2)nc2cc(OCc3ccccc3)ccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 12/20 0.52
RAB9A P51151 12/20 0.52
GFER P55789 2/20 0.52
SMN1; SMN2 Q16637 4/20 0.49
KDM4E B2RXH2 3/20 0.49
MAOB P27338 1/20 0.49
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
HDAC6 Q9UBN7 2/20 0.47
TP53 P04637 4/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
NFKB1 P19838 2/20 0.47
NFKB2 Q00653 2/20 0.47
RELA Q04206 2/20 0.47
ALDH1A1 P00352 2/20 0.47
ALOX15 P16050 1/20 0.47
MAPT P10636 3/20 0.46
PKM P14618 2/20 0.46
HTT P42858 2/20 0.46
GAA P10253 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6636758 0.83 KLK1 (0.66) NPC1RAB9AGFERHDAC6
SCHEMBL6637018 0.80 NPC1 (0.48) NPC1RAB9AGFERSMN1; SMN2KDM4E
SCHEMBL7447463 0.80 NPC1 (0.72) NPC1RAB9AGFERSMN1; SMN2KDM4E
SCHEMBL6775295 0.78 HDAC6 (0.64) NPC1RAB9AHDAC6LMNA
SCHEMBL14914339 0.78 HDAC6 (0.51) NPC1RAB9AGFERSMN1; SMN2KDM4E
SCHEMBL30937423 0.76 HDAC6 (0.62) NPC1RAB9ASMN1; SMN2KDM4EHDAC6
SCHEMBL6637343 0.76 HDAC6 (0.49) NPC1RAB9AGFERSMN1; SMN2KDM4E
SCHEMBL19157559 0.76 F2 (0.48) NPC1RAB9AGFERSMN1; SMN2KDM4E
SCHEMBL6806474 0.76 MAPT (0.72) RAB9AKDM4EMAOBKMT2AMEN1
SCHEMBL19339630 0.75 HDAC6 (0.48) NPC1RAB9AGFERSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2004-06-09 EP disclosed
US-6121308-A INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBONYLMETHYL) -QUINOLINE-8-SULPHONYLAMINO)-INDOLE BOEHRINGER INGELHEIM KG (DE) 2000-09-19 US disclosed